Benign Prostatic Hyperplasia
- PMID: 31030823
- DOI: 10.1016/j.pop.2019.02.003
Benign Prostatic Hyperplasia
Abstract
Benign prostatic hyperplasia (BPH) is a common condition in aging men that is frequently associated with troublesome lower urinary tract symptoms (LUTS). The American Urologic Association Symptom Index is a validated, self-administered tool that is used to diagnose LUTS, guide initial treatment, and assess treatment response. Watchful waiting is an option for men with mild symptoms. Pharmacologic treatment includes alpha-adrenergic blockers and 5-alpha reductase inhibitors. There is no evidence to support the use of herbal supplements in the treatment of LUTS. Surgical therapy is effective and indicated for men with complications from BPH or who fail medical therapy.
Keywords: 5-alpha reductase inhibitors; Alpha-adrenergic blockers; Benign prostatic hyperplasia; Lower urinary tract symptoms; Transurethral resection of the prostate.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
[Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].Prog Urol. 2012 Dec;22(16):977-88. doi: 10.1016/j.purol.2012.10.001. Epub 2012 Nov 6. Prog Urol. 2012. PMID: 23178093 French.
-
The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.Prostate. 2021 Sep;81(13):944-955. doi: 10.1002/pros.24190. Epub 2021 Jul 20. Prostate. 2021. PMID: 34288015 Free PMC article.
-
Management of Benign Prostatic Hyperplasia.Annu Rev Med. 2016;67:137-51. doi: 10.1146/annurev-med-063014-123902. Epub 2015 Sep 2. Annu Rev Med. 2016. PMID: 26331999 Review.
-
Medical therapy for benign prostatic hyperplasia: a review.Can J Urol. 2015 Oct;22 Suppl 1:7-17. Can J Urol. 2015. PMID: 26497339 Review.
-
Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.Eur Urol. 2017 Apr;71(4):570-581. doi: 10.1016/j.eururo.2016.09.032. Epub 2016 Oct 4. Eur Urol. 2017. PMID: 27717522 Free PMC article. Review.
Cited by
-
Propensity score-matched analysis comparing perioperative, functional, and safety outcomes between thulium fiber laser and bipolar enucleation of the prostate performed by a single surgeon with two years of follow-up.Investig Clin Urol. 2024 Mar;65(2):139-147. doi: 10.4111/icu.20230270. Investig Clin Urol. 2024. PMID: 38454823 Free PMC article.
-
Association between dietary phytochemical index and risk of benign prostatic hyperplasia: a case-control study.J Health Popul Nutr. 2024 Mar 1;43(1):35. doi: 10.1186/s41043-024-00531-5. J Health Popul Nutr. 2024. PMID: 38429831 Free PMC article.
-
Evaluating the Impact of Benign Prostatic Hyperplasia Surgical Treatments on Sexual Health.Biomedicines. 2024 Jan 5;12(1):110. doi: 10.3390/biomedicines12010110. Biomedicines. 2024. PMID: 38255215 Free PMC article. Review.
-
Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride.J Pers Med. 2023 Oct 31;13(11):1566. doi: 10.3390/jpm13111566. J Pers Med. 2023. PMID: 38003881 Free PMC article.
-
Benign prostatic hyperplasia and metabolic syndrome; prevalence and association: a cross-sectional study in Syria.BMC Urol. 2023 Nov 16;23(1):187. doi: 10.1186/s12894-023-01365-9. BMC Urol. 2023. PMID: 37974176 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
